摘要:
Compounds of formula (I) ##STR1## in which A is (CH.sub.2).sub.n in which n is 1-10, preferably 3 or 5, and R is the acyl group from a known anti-inflammatory agent, exhibit high anti-inflammatory activity. The mechanism of action is novel because they do not release the anti-inflammatory agent in the body but exhibit an activity superior to the activity of the known anti-inflammatory agent. The compounds are also active in combating bone calcium loss.
摘要:
4,5-Dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethanes having therapeutic activities, a process for the preparation thereof and pharmaceutical compositions containing them.
摘要:
The present invention concerns a compound of formula (I) ##STR1## wherein: X is selected from H and OH;R is a residue which, linked to the ##STR2## group, forms an amino acid; the enantiomers and racemic mixtures thereof; and the pharmaceutically acceptable salts thereof.The invention further concerns a pharmaceutical composition which comprises the above compound or salts thereof and the use of the compound for treating an articular pathology.
摘要:
This application describes 3-arylalkyl esters of 4,5-dihydro-9,10-dioxo-2-anthracenecarboxylic acid and a process for making them. Also described is a method of using the compounds in the treatment of arthritis.